AccuStem Sciences, Inc. (ACUT)
OTCMKTS · Delayed Price · Currency is USD
0.14745
-0.00255 (-1.70%)
At close: Oct 8, 2026
AccuStem Sciences Market Cap
AccuStem Sciences has a market cap or net worth of $2.37 million as of October 15, 2026. It is the 47,521st most valuable company in the world and the 6,383rd biggest in the United States. Its market cap has decreased by 89.69% in one year.
Market Cap
2.37M
Enterprise Value
2.42M
Revenue
98.40K
Global Rank
Country Rank
#6,383 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since March 2, 2022, AccuStem Sciences's market cap has decreased from 20.42M to 2.37M, a decrease of -88.39%. That is a compound annual growth rate of -37.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 2.37M | -81.87% |
| Dec 31, 2025 | 13.07M | 157.22% |
| Dec 31, 2024 | 5.08M | -28.40% |
| Dec 29, 2023 | 7.10M | -53.62% |
| Dec 30, 2022 | 15.31M | -25.04% |
| Mar 2, 2022 | 20.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Affymax | 3.10M |
| Vaccinex | 2.81M |
| Aditxt | 2.79M |
| Bioxytran | 2.61M |
| GPL Holdings | 2.56M |
| Enzolytics | 2.42M |
| Mosaic ImmunoEngineering | 2.41M |
| Abpro Holdings | 2.17M |